Uncertainty Over Applera-MJ Patent Lawsuit Tempers Bio-Rad s Fourth-Quarter Outlook | GenomeWeb

If a September court order barring Bio-Rad Laboratories unit MJ Research from selling certain products remains in place, it could reduce the firm's fourth-quarter revenue by as much as $15 million, Bio-Rad executives said during its third-quarter conference call last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.